7th Circ. Casts A Wary Eye On Supplement Labeling Deal
A Seventh Circuit panel on Friday grilled NBTY Inc. and plaintiffs' attorneys about the $6.5 million settlement they struck in a glucosamine supplement false labeling class action, questioning how the class...To view the full article, register now.
Already a subscriber? Click here to view full article